AVNS

Company Snapshot

Founded: 2014
Entity Type: Public
Employees: 2,227
Region: U.S.
Revenue: $687.8 Millions
Revenue Year: 2024
Headquarter: Georgia, U.S.
Key Geographics: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Corporate Address: 5405 Windward Parkway Suite 100 South, Alpharetta Georgia 30004 U.S. Tel. +1-(844)-428-2667 www.avanos.com

Company Overview

Avanos Medical Inc. (AVNS) is a leading global provider of medical technology committed to enhancing patient outcomes. The company operates through a single segment, which delivers medical device solutions to healthcare providers and patients worldwide, focusing on two platforms: Digestive Health and Pain Management and Recovery. The company’s expertise extends to digestive health solutions, NICU pharmacy products, and IV therapy solutions, supporting comprehensive healthcare needs with innovation and quality care.

The company caters to the infusion pump and devices market through its Pain Management & Recovery portfolio. This portfolio is divided into Surgical pain and recovery and Interventional pain. Avanos offers surgical pain and recovery products like ON-Q, ambIT surgical pain pumps, and Game Ready cold and compression therapy systems. Additionally, interventional pain solutions include COOLIEF pain therapy, OrthogenRx’s knee osteoarthritis HA pain relief injections, and Diros’ RFA products for chronic pain management.

Avanos has manufacturing facilities in the U.S. and Mexico. The company’s products are marketed directly to hospitals and healthcare providers, often distributed through third-party wholesale channels. However, some sales are made directly to healthcare facilities and other end users. Avanos develops, manufactures, and distributes its well-established brands in over 90 countries.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

AVNS In Reports

Infusion Pumps and Devices: Technologies and Global Markets

Our detailed report on the Infusion Pumps and Devices Markets report includes global revenue ($ Million) for base year data of 2024, estimated year data of 2025, and forecasts through 2030.

Infusion Pumps and Devices: Technologies and Global Markets

BCC Research Market Analyst says global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a CAGR of 7.7%.

Infusion Pumps and Devices: Technologies and Global Markets

Global market for infusion pumps was valued at $9.8 billion in 2021 and is estimated to grow from $10.3 billion in 2022 to $15.0 billion in 2027 with CAGR of 7.7%.

Company's Business Segments

  • Medical Device Solutions : The company offers clinically-superior medical device solutions for pain management, digestive health, and respiratory health.

Applications/End User Industries

  • Hospitals
  • Clinics
  • Physician Practices
  • Home Healthcare Settings
  • Third-party Wholesale Distributors
  • Group Purchasing Organizations (GPOs)
AI Sentiment